Skip to content
MedsAcross

Medicine

Paricalcitol 2 mcg capsule

Paricalcitol · Oral
Available on requestPrescription onlyUS FDAGeneric name

Paricalcitol 2 mcg capsule is a generic prescription medicine for oral use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store paricalcitol capsules at 25°C (77°F). Excursions permitted between 15°-…

Key facts

Active ingredient (INN)
Paricalcitol
Brand
Sold under the generic name
Strength
2 mcg
Dosage form
Capsule
Route
Oral
Packs
30 capsules, 100 capsules, 500 capsules and 10 more
Manufacturers
Dr. Reddy's LaboratoriesIndiaMarksans PharmaIndiaAurobindo PharmaIndiaTime Cap LaboratoriesIndiaAmneal PharmaceuticalsBryant Ranch PrepackBionpharma
Origin register
US FDA, United States
Storage
Store paricalcitol capsules at 25°C (77°F). Excursions permitted between 15°- 30°C (59°- 86°F). See USP Controlled Room Temperature.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
H05BX02 Paricalcitol
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
25 June 2014
Identifiers
RxCUI 577315, 577317, 577324DailyMed set ID 755476e5-62a2-4f01-92a3-307e192ad42c, f593b575-7537-4531-87fc-c1b0814fd018, 52ca3d88-e85d-44a9-8aa7-eb25a8a73f6f +5NDC 69452-146, 49483-688, 63629-2453 +5Application ANDA202539, ANDA204948, ANDA207672 +2

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
30 capsule, liquid filled in 1 bottle65862-937-30Aurobindo PharmaIndia14 January 2016
100 capsule, liquid filled in 1 bottle55111-664-01Dr. Reddy's LaboratoriesIndia25 June 2014
500 capsule, liquid filled in 1 bottle55111-664-05Dr. Reddy's LaboratoriesIndia25 June 2014
30 capsule, liquid filled in 1 bottle55111-664-30Dr. Reddy's LaboratoriesIndia25 June 2014
3 blister pack in 1 carton / 10 capsule, liquid filled in 1 blister pack55111-664-81Dr. Reddy's LaboratoriesIndia25 June 2014
30 capsule, liquid filled in 1 bottle25000-014-03Marksans PharmaIndia31 December 2016
4 bag in 1 box / 7000 capsule, liquid filled in 1 bag25000-014-49Marksans PharmaIndia31 December 2016
30 capsule, liquid filled in 1 bottle49483-688-03Time Cap LaboratoriesIndia3 January 2017
30 capsule in 1 bottle65162-823-03Amneal Pharmaceuticals15 January 2016
90 capsule in 1 bottle65162-823-09Amneal Pharmaceuticals15 January 2016
30 capsule in 1 bottle, plastic69452-146-13Bionpharma16 August 2016
30 capsule in 1 bottle, plastic63629-2453-1Bryant Ranch Prepack8 March 2021
30 capsule in 1 bottle, plastic72162-1916-3Bryant Ranch Prepack3 April 2024

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 17 April 1998Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Paricalcitol 2 mcg capsule.

Compare 1

Other strengths and forms of Paricalcitol

Clinical summary

Paricalcitol is a vitamin D2 analog indicated for the prevention and treatment of secondary hyperparathyroidism in patients 5 years of age and older with chronic kidney disease (CKD) on dialysis. MedsAcross supplies Paricalcitol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Paricalcitol

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Paricalcitol 2 mcg capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.